Veterinary Medicines

EURICAN L-MULTI SUSPENSION FOR INJECTION

Not authorised
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
  • Leptospira interrogans, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
Download as PDF

Product identification

Medicine name:
EURICAN L-MULTI SUSPENSION FOR INJECTION
Eurican Lmulti, suspenzija za injekciju
Active substance:
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
  • Leptospira interrogans, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Croatia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/20-01/498
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0288/001

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 11/08/2022
Download